X4 Pharmaceuticals (XFOR) Prepaid Assets (2017 - 2025)
X4 Pharmaceuticals posted quarterly Prepaid Assets of $3.5 million for Q4 2025, down 36.88% year-on-year from $5.6 million in Q4 2024, and down 28.39% on a QoQ basis from $4.9 million in Q3 2025.
X4 Pharmaceuticals (XFOR) has 9 years of Prepaid Assets data on file, last reported at $3.5 million in Q4 2025.
- For the quarter ending Q4 2025, Prepaid Assets fell 36.88% year-over-year to $3.5 million; the trailing twelve-month figure through Dec 2025 stood at $3.5 million (down 36.88% YoY), and the FY2025 full-year result was $3.5 million, down 36.88% from the prior year.
- Prepaid Assets for Q4 2025 stood at $3.5 million, down from $4.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.3 million in Q4 2023 and bottomed at $3.5 million in Q4 2025.
- The 5-year median for Prepaid Assets is $5.0 million (2022), against an average of $4.9 million.
- The widest annual swing landed in 2021, when Prepaid Assets soared 45.14%; it then tumbled 36.88% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $5.3 million in 2021, then rose by 8.66% to $5.8 million in 2022, then gained by 25.68% to $7.3 million in 2023, then fell by 23.43% to $5.6 million in 2024, then tumbled by 36.88% to $3.5 million in 2025.
- The last three Prepaid Assets figures came in at $3.5 million (Q4 2025), $4.9 million (Q3 2025), and $5.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | X4 Pharmaceuticals | 182.28 Mn | 182.28 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.53 Mn |
| Sep 30, 2025 | 4.93 Mn |
| Jun 30, 2025 | 4.96 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 5.59 Mn |
| Sep 30, 2024 | 4.48 Mn |
| Jun 30, 2024 | 4.98 Mn |
| Mar 31, 2024 | 5.76 Mn |
| Dec 31, 2023 | 7.30 Mn |
| Sep 30, 2023 | 5.80 Mn |
| Jun 30, 2023 | 5.52 Mn |
| Mar 31, 2023 | 4.16 Mn |
| Dec 31, 2022 | 5.81 Mn |
| Sep 30, 2022 | 4.95 Mn |
| Jun 30, 2022 | 4.36 Mn |
| Mar 31, 2022 | 3.59 Mn |
| Dec 31, 2021 | 5.34 Mn |
| Sep 30, 2021 | 3.66 Mn |
| Jun 30, 2021 | 5.16 Mn |
| Mar 31, 2021 | 4.25 Mn |
| Dec 31, 2020 | 3.68 Mn |
| Sep 30, 2020 | 4.47 Mn |
| Jun 30, 2020 | 5.63 Mn |
| Mar 31, 2020 | 3.48 Mn |
| Dec 31, 2019 | 1.10 Mn |
| Sep 30, 2019 | 1.23 Mn |
| Jun 30, 2019 | 1.60 Mn |
| Mar 31, 2019 | 2.37 Mn |
| Dec 31, 2018 | 1.21 Mn |
| Sep 30, 2018 | 1.26 Mn |
| Jun 30, 2018 | 4.39 Mn |
| Mar 31, 2018 | 338,000.00 |
| Dec 31, 2017 | 1.13 Mn |